Trial Profile
Intranasal fluticasone furoate +/- intraocular olopatadine vs intraocular olopatadine alone in seasonal allergic rhinitis patients undergoing nasal allergan challenge
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2012
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary) ; Olopatadine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 06 Mar 2012 Results presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 06 Mar 2012 New trial record